Literature DB >> 18835556

Expression of the tachykinin receptor mRNAs in healthy human colon.

Nadia Jaafari1, Guoqiang Hua, José Adélaïde, Yvon Julé, Jean Imbert.   

Abstract

Tachykinins are a family of neuropeptides, involved in a variety of physiological and pathological processes occurring in the gastrointestinal tract. They act via three distinct types of receptors, tachykinin NK(1), NK(2), and NK(3) receptors, which belong to the family of G protein-coupled receptors. The aim of the present study was to characterize, for the first time in the healthy human colon, the TACR(1), TACR(2) and TACR(3) mRNAs encoding the three different tachykinin receptors and to measure their relative expression by quantitative reverse transcription-PCR assay. Our results confirm the broad distribution of the tachykinin receptors but evidenced significant differences in the expression level of their respective mRNAs. A higher expression level of the TACR2 mRNA alpha isoform, the gene encoding the functional tachykinin NK(2) receptor, was observed in comparison to TACR1 and TACR3 mRNAs genes encoding for NK(1) and NK(3) receptors respectively. The prevalence of the TACR2 mRNA alpha isoform strongly suggests a major involvement of tachykinin NK(2) receptor in the regulation of human colonic functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835556     DOI: 10.1016/j.ejphar.2008.09.024

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Association of genetic variants in tachykinins pathway genes with colorectal cancer risk.

Authors:  Yunxian Yu; Yifeng Pan; Mingjuan Jin; Mingwu Zhang; Shanchun Zhang; Qilong Li; Xia Jiang; Hui Liu; Jing Guo; He Liu; Kun Chen
Journal:  Int J Colorectal Dis       Date:  2012-06-26       Impact factor: 2.571

2.  Neurokinin-2 receptor polymorphism predicts lymph node metastasis in colorectal cancer patients.

Authors:  Weijia Fang; Caiyun Fu; Xiaogang Chen; Xiaozhou Mou; Fanlong Liu; Jiong Qian; Peng Zhao; Yulong Zheng; Y I Zheng; Jing Deng; Pingjiang Ye; Yifei Wang; Shusen Zheng
Journal:  Oncol Lett       Date:  2015-03-06       Impact factor: 2.967

3.  Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer.

Authors:  Kiyoshi Misawa; Takeharu Kanazawa; Yuki Misawa; Atsushi Imai; Takayuki Uehara; Daiki Mochizuki; Shiori Endo; Goro Takahashi; Hiroyuki Mineta
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-19       Impact factor: 4.553

Review 4.  Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review.

Authors:  Sara J Menown; Javier A Tello
Journal:  Adv Ther       Date:  2021-09-12       Impact factor: 3.845

Review 5.  G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?

Authors:  Takeharu Kanazawa; Kiyoshi Misawa; Yuki Misawa; Takayuki Uehara; Hirofumi Fukushima; Gen Kusaka; Mikiko Maruta; Thomas E Carey
Journal:  Toxins (Basel)       Date:  2015-08-05       Impact factor: 4.546

6.  Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment.

Authors:  Mengyu Sun; Jieping Qiu; Huazheng Zhai; Yaoqun Wang; Panpan Ma; Mengyin Li; Bo Chen
Journal:  Med Sci Monit       Date:  2020-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.